Agonist-induced down-regulation of the m4 muscarinic acetylcholine receptor occurs without changes in receptor mRNA steady-state levels.
The regulation of m4 muscarinic acetylcholine receptor mRNA expression by receptor activation was studied in N1E-115 neuroblastoma and AtT-20 pituitary cells that endogeneously express the m4 muscarinic receptor. Receptor concentration was measured by binding of the muscarinic receptor radioligand [3H]quinuclidinyl benzilate, and RNA-RNA solution hybridization/RNase protection assay with a m4 receptor-specific [32P]-cRNA probe was used to evaluate the levels of receptor mRNA. Treatment of both cell lines with a receptor-saturating concentration of the agonist carbachol decreased receptor number. However, there was no change in steady-state levels of m4 mAChR mRNA in both cell lines. Determination of mRNA stability in the presence of the transcription blocker actinomycin D revealed that carbachol treatment increased half-life of receptor mRNA in N1E-115 cells, but not in AtT-20 cells, suggesting that receptor activation can regulate m4 receptor mRNA stability dependently on cell type. Analysis of receptor degradation kinetics in the presence of the protein synthesis inhibitor cycloheximide showed that receptor down-regulation in N1E-115 and AtT-20 cells is sufficiently accounted for by increased receptor degradation. These results indicate than m4 muscarinic receptor down-regulation is substantially different from that of the muscarinic receptor subtypes m2 and m3 which is reported to be associated with agonist-induced reduction in receptor mRNA.
Lenz
W
W
Institut für Pharmakologie, Universität GH Essen, Germany.
Petrusch
C
C
Jakobs
K H
KH
van Koppen
C J
CJ
D000818:Animals; D002217:Carbachol / Q000494:pharmacology*; D002460:Cell Line; D003513:Cycloheximide; D003609:Dactinomycin; D015536:Down-Regulation; D007700:Kinetics; D051379:Mice; D018721:Muscarinic Agonists; D009447:Neuroblastoma / Q000378:metabolism; D009693:Nucleic Acid Hybridization; D010902:Pituitary Gland / Q000378:metabolism; D011813:Quinuclidinyl Benzilate; D012333:RNA, Messenger / Q000032:analysis*; D011976:Receptors, Muscarinic / Q000235:genetics* / Q000378:metabolism*
D018721:Muscarinic Agonists; D012333:RNA, Messenger; D011976:Receptors, Muscarinic; D003609:Dactinomycin; D011813:Quinuclidinyl Benzilate; D002217:Carbachol; D003513:Cycloheximide